Evaluation of the Efficacy, Safety, and Clinical Outcomes of Ginsenosides as Adjuvant Therapy in Hepatocellular Carcinoma: A Meta-Analysis and Systematic Review

Evaluation of the Efficacy, Safety, and Clinical Outcomes of Ginsenosides as Adjuvant Therapy in Hepatocellular Carcinoma: A Meta-Analysis and Systematic Review

Background: Ginsenosides (GS), including total GS, Rh2, Rg3 and compound K (CK), have been utilized as adjuvants in transarterial chemoembolization (TACE), surgery, and chemotherapy for hepatocellular carcinoma (HCC) therapy. However, the safety and efficacy of such combination treatments have been...

Full description

Bibliographic Details
Main Authors: Renjie Zhang MD, Yiling Liao MD, Yuan Gao MD, Hengyu Tian MD, Shenfeng Wu MD, Qingteng Zeng MD, Qinghua He MD, Ruikun Zhang MD, Chunshan Wei PHD, Jialin Liu PhD
Format: Article
Language:English
Published: SAGE Publishing 2024-10-01
Series:Integrative Cancer Therapies
Online Access:https://doi.org/10.1177/15347354241293790

Internet

https://doi.org/10.1177/15347354241293790

Similar Items